NYSE - Nasdaq Real Time Price • USD
Stryker Corporation (SYK)
At close: 4:00 PM EDT
After hours: 5:09 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 24 | 23 | 28 | 28 |
| Avg. Estimate | 2.36 | 2.85 | 11.85 | 13.26 |
| Low Estimate | 2.28 | 2.76 | 11.46 | 12.11 |
| High Estimate | 2.48 | 2.96 | 12 | 13.66 |
| Year Ago EPS | 2.14 | 2.54 | 10.6 | 11.85 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 28 | 27 |
| Avg. Estimate | 5.1B | 5.4B | 22.18B | 23.87B |
| Low Estimate | 5B | 5.34B | 22.01B | 23.48B |
| High Estimate | 5.14B | 5.59B | 22.34B | 24.32B |
| Year Ago Sales | 4.56B | 4.82B | 20.5B | 22.18B |
| Sales Growth (year/est) | 11.90% | 12.00% | 8.20% | 7.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2 | 2.38 | 2.43 | 3.27 |
| EPS Actual | 2.14 | 2.54 | 2.46 | 3.46 |
| Difference | 0.14 | 0.16 | 0.03 | 0.19 |
| Surprise % | 7.00% | 6.70% | 1.20% | 5.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.36 | 2.85 | 11.85 | 13.26 |
| 7 Days Ago | 2.36 | 2.85 | 11.85 | 13.26 |
| 30 Days Ago | 2.36 | 2.85 | 11.85 | 13.25 |
| 60 Days Ago | 2.36 | 2.85 | 11.85 | 13.25 |
| 90 Days Ago | 2.5 | 2.82 | 11.56 | 12.86 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | 2 |
Growth Estimates
| CURRENCY IN USD | SYK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 10.30% | -- | -- | 1.60% |
| Next Qtr. | 12.20% | -- | -- | 10.50% |
| Current Year | 11.80% | -- | -- | 5.20% |
| Next Year | 11.90% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 11.12% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 8.95% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | RBC Capital: Outperform to Outperform | 4/15/2024 |
| Maintains | TD Cowen: Buy to Buy | 4/11/2024 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/4/2024 |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/15/2024 |
| Maintains | Citigroup: Buy to Buy | 1/31/2024 |
Related Tickers
BSX Boston Scientific Corporation
67.33
-0.13%
ZBH Zimmer Biomet Holdings, Inc.
119.43
+0.08%
MDT Medtronic plc
79.48
+0.37%
EW Edwards Lifesciences Corporation
85.94
-0.59%
DXCM DexCom, Inc.
130.71
-2.67%
ALGN Align Technology, Inc.
298.98
-0.78%
ABT Abbott Laboratories
107.28
+1.91%
SWAV Shockwave Medical, Inc.
329.00
+0.45%
PODD Insulet Corporation
166.25
+0.92%
ITGR Integer Holdings Corporation
116.62
-1.03%